MARKET

RENXF

RENXF

Renalytix Plc
OTCMQB
0.036
NaN%
Closed 09:30 04/09 EDT
OPEN
--
PREV CLOSE
0.036
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.163
52 WEEK LOW
0.036
MARKET CAP
15.69M
P/E (TTM)
-0.6838
1D
5D
1M
3M
1Y
5Y
1D
Renalytix Grows Revenue and Integration Footprint as It Pursues National Rollout of KidneyintelX.dkd
TipRanks · 03/26 07:22
Renalytix Lifts Revenue as KidneyintelX Expansion and Distribution Talks Gather Pace
TipRanks · 03/26 07:20
Renalytix CEO Boosts Stake as Kidney Disease Test Rollout Advances
TipRanks · 02/13 14:32
Renalytix Interim CFO Joel Jung Purchases 500 ADS in Company
Reuters · 02/13 12:15
Renalytix CFO Increases Stake as KidneyintelX.dkd Deployment Expands
TipRanks · 02/13 07:07
Renalytix CFO Increases Stake as Kidney Disease Test Gains Traction
TipRanks · 02/12 07:42
Renalytix CEO Increases Stake Amid Expansion of Kidney Disease Test
TipRanks · 02/12 07:20
Renalytix Eyes Revenue Growth as Kidney Diagnostic Expands U.S. Footprint
TipRanks · 02/11 07:14
More
About RENXF
Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. KidneyIntelX, is a vitro diagnostic platform, employs a proprietary algorithm that combines diverse data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record or EHR, systems, to generate a patient risk score. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Webull offers Renalytix PLC stock information, including OTCMQB: RENXF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RENXF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RENXF stock methods without spending real money on the virtual paper trading platform.